Mito-Esc and metformin delayed vascular aging and improved atherosclerosis by activating mitochondrial function and inhibiting oxidative stress and inflammation via the AMPK-SIRT1/SIRT6 axis. The gene discussed is SIRT1; the disease is atherosclerosis.